Results 181 to 190 of about 2,989,026 (346)

The Need for a Systems Biology Approach in Cancer Explained. [PDF]

open access: yesInt J Mol Sci
Zhu H   +12 more
europepmc   +1 more source

Systems Biology Profiling of AMD on the Basis of Gene Expression [PDF]

open access: gold, 2013
Mones Abu‐Asab   +3 more
openalex   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

Rethinking medical education through systems biology to address complexity. [PDF]

open access: yesNPJ Syst Biol Appl
David L   +3 more
europepmc   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Mapping physiology: A systems biology approach for the development of alternative methods in toxicology

open access: gold
Bernard Staumont   +13 more
openalex   +1 more source

“Gestaltomics”: Systems Biology Schemes for the Study of Neuropsychiatric Diseases [PDF]

open access: gold, 2017
Nora A. Gutierrez Najera   +2 more
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy